Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling.

Kantor AB, Deng J, Waubant E, Lin H, Becker CH, Lacy JR, Perrone AM, Bennett D, Goelz SE., J Neuroimmunol. 188(1-2):103-16. Epub 2007 Jul 5., 2007 Aug 01

Investigators

Joseph R. Lacy, M.D.

Abstract

We applied broad-based phenotypic profiling to identify pharmacodynamic markers for interferon-beta in multiple sclerosis subjects.

A strong pharmacodynamic effect was observed 1.5 (short-term) vs. 6 days post weekly injection. Hundreds of differences were observed at a p-value <0.001. Most major cell populations, including neutrophils, B cells, CD4 T cells and CD8 T cells, decreased in absolute counts at 1.5 days. The striking exception was monocytes, which increased substantially.

Changes in multiple monocyte-associated cell surface molecules and monocyte related soluble factors were also observed, including: HLA class II, CCR5, CD38, CD40, CD54, CD64, CD69, CD86, CD101, TLR2, TLR4 and MCP2.

These results demonstrate that new hypotheses can be generated from broad molecular and cellular profiling in a clinical setting and provide an approach to identify candidate pharmacodynamic markers to evaluate new drug formulations, dosing and bioequivalence.

Pubmed Abstract

Pubmed AbstractOpens New Window

Associated Topics

Related Publications

Rethinking STOP-ROP: Is it worthwhile trying to modulate excessive VEGF levels in prethreshold ROP eyes by systemic intervention? A review of the role of oxygen, light adaptation state, and anemia in prethreshold ROP.

Gaynon MW.
Retina. 26(7 Suppl):S18-23.
2006 Sep 01

Pseudoduplication of the optic disk.

Sun Y, Ng JK, Gaynon MW.
Retin Cases Brief Rep. 5(2):144-5. doi: 10.1097/ICB.0b013e3181cc2135.
2011 Apr 01

Brain regions showing increased activation by threat-related words in panic disorder.

Maddock RJ1, Buonocore MH, Kile SJ, Garrett AS.Author information 1Department of Radiology, University of California Davis, 4801 X St, Sacramento, California 95817, USA. rjmaddock@ucdaris.edu
Neuroreport. 2003 Mar
2003 Mar 20

Neuropsychiatric update: neuroimaging schizophrenia.

Psychopharmacol Bull. 2007;40(4):156-67.Neuropsychiatric update: neuroimaging schizophrenia.Kile SJ.
Psychopharmacol Bull. 2007;40(4):156-67.Neuropsychiatric update: neuroimaging schizophrenia.Kile SJ.
2007 Jul 20

Alzheimer abnormalities of the amygdala with Klüver-Bucy syndrome symptoms: an amygdaloid variant of Alzheimer disease

Arch Neurol. 2009 Jan;66(1):125-9. doi: 10.1001/archneurol.2008.517.Alzheimer abnormalities of the amygdala with Klüver-Bucy syndrome symptoms: an amygdaloid variant of Alzheimer disease.Kile SJ1, Ellis WG, Olichney JM, Farias S, DeCarli C.Author information 1Department of Neurology, University of California at Davis,
Arch Neurol. 2009 Jan;
2009 Jan 20